7.750USD+5.95%Mkt Cap: 207.46M USDP/E: —Last update: 2026-06-01
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a la…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap207.46M USD
Enterprise Value143.28M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.55M USD
Revenue/Share—
Last Price7.750 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees21
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)1.12
PEG—
EV/EBITDA-4.79
EV/Revenue—
P/S—
P/B4.94
EPS (TTM)-2.25
EPS (Forward)6.56
52W Range
3.71055% of range11.00
52W High11.00 USD
52W Low3.710 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-87.94%
ROA-54.04%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-31.32M USD
CapEx (TTM)24.00K USD
FCF Margin—
FCF Yield-3.43%
Net Debt-53.77M USD
Net Debt/EBITDA1.80
Balance Sheet
Debt/Equity0.01
Current Ratio2.40
Quick Ratio2.06
Book Value/Sh1.494 USD
Cash/Share2.044 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 20, 2025
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)41.00 USD
Target Range15.00 USD – 90.00 USD
# Analysts10
Ownership
Shares Out.26.70M
Float24.28M
Insiders2.36%
Institutions37.65%
Short Interest
Short Ratio3.7d
Short % Float7.78%
Short % Out.7.60%
Shares Short2.03M
Short (prev mo.)2.16M
Technical
SMA 507.275 (+6.5%)
SMA 2005.941 (+30.5%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)598.28K
Avg Vol (10d)766.13K
Technical Indicators
RSI (14)45.8
MACD-0.0223
MACD Signal0.1254
MACD Hist.-0.1477
BB Upper8.736 USD
BB Middle7.849 USD
BB Lower6.962 USD
BB Width22.61%
ATR (14)0.4857 USD
Vol Ratio (20d)0.71x